I think you read updates to the brief today based on this new entry - but I will re-iterate to see notes from today. #5 and #23 were really well liked but want to see something with the I too without getting too complex. And...word to be careful that we can still see it is a U. People really wanted to see what you might do with this and maybe even #4 with the new feedback given in the brief today. #68 and 67 are too busy - too much going on...not sure what the little figures do for it. We do LOVE, LOVE the slogan/tag line under the entries saying "GLYCOENGINEERED...." Really nice. Please re-read the brief for comments dated 11/5 and see below.
We asked to be on U and I and simple enough to see the word when looking at it. See updated brief under comments.
I would say that feedback was on less focus on hexagon, more focus on the U and the I or even tying them together somehow, making them stand out as a combo....We decided to use GENUINE or another name RUBICON for our first trial and UNITY for a different trial (combines Ublituximab and TGR-1202 for U and T).
That said however - for GENUINE - remember the importance of the U and the I being key. We like the word and what it stands for - we see the chance to highlight "our" drug with "U" (an antibody) and the idea of a combo with the I drug (a BCR receptor inhibitor of BTK - less important). Maybe even tying them together somehow. Please see the updated comments at brief about that and also about focusing on the science behind the drugs possibly (shapes of the pathways inhibited - search antiCD20 antibody or BCR receptor) in the logo or any design element. It is valuable feedback from our CEO, COO and team to make a decision with me. THANKS AGAIN!